{"auto_progress_calculation":false,"computation_units":"US dollar, Millions, 2022 constant prices","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":["Recipient country","Type of flow","Type of finance","Assistance type","Subsector","Policy marker"],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"Total net official development assistance to medical research and basic health sectors","graph_titles":[],"graph_type":"line","indicator_name":"Total net official development assistance to medical research and basic health sectors","indicator_number":"3.b.2","national_geographical_coverage":"Canada","page_content":"","permalink":"","precision":[],"progress_calculation_options":[],"progress_status":"not_available","reporting_status":"complete","sort":"","standalone":false,"tags":[],"\u00ef\u00bb\u00bfcomposite_breakdown_label":"","SDG_GOAL":"Goal 3: Ensure healthy lives and promote well-being for all at all ages","SDG_TARGET":"Target 3.b : Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","SDG_INDICATOR":"Indicator 3.b.2: Total net official development assistance to the medical research and basic health sectors","STAT_CONC_DEF":"<strong>Definition:</strong>\n<br><br>\nGross disbursements of total ODA from all donors to medical research and basic health sectors.\n<br><br>\n<strong>Concepts:</strong>\n<br><br>\nODA: The Development Assistance Committee (DAC) defines ODA as \u201cthose flows to countries and territories on the DAC List of ODA Recipients and to multilateral institutions which are \n<br><br>\ni. provided by official agencies, including state and local governments, or by their executive agencies; and \n<br><br>\nii. each transaction is administered with the promotion of the economic development and welfare of developing countries as its main objective; and is concessional in character and conveys a grant element of at least 25 per cent (calculated at a rate of discount of 10 per cent). (See <a href=\"https://www.oecd.org/en/topics/sub-issues/oda-eligibility-and-conditions/official-development-assistance--definition-and-coverage.html\">https://www.oecd.org/en/topics/sub-issues/oda-eligibility-and-conditions/official-development-assistance--definition-and-coverage.html)</a>\n<br><br>\nMedical research and basic health sectors are as defined by the DAC. Medical research refers to CRS sector code 12182 and basic health covers all codes in the 122 series (see here: <a href=\"http://www.oecd.org/dac/stats/purposecodessectorclassification.htm\">http://www.oecd.org/dac/stats/purposecodessectorclassification.htm)</a>\n","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"   ","SDG_GOAL__GLOBAL":"Goal 3: Ensure healthy lives and promote well-being for all at all ages","SDG_TARGET__GLOBAL":"Target 3.b : Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","SDG_INDICATOR__GLOBAL":"Indicator 3.b.2: Total net official development assistance to the medical research and basic health sectors","un_designated_tier":"Tier I","un_custodian_agency":"Organisation for Economic Co-operation and Development (OECD)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0B-02.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata","source_active_1":true,"source_url_text_1":"CRS: Creditor Reporting System (flows)","source_url_1":"https://data-explorer.oecd.org/vis?lc=en&pg=0&snb=24&vw=tb&df[ds]=dsDisseminateFinalCloud&df[id]=DSD_CRS%40DF_CRS&df[ag]=OECD.DCD.FSD&df[vs]=1.3&dq=CAN.DPGC.122%2B12182.100._T._T.D.Q._T..&pd=2015%2C&to[TIME_PERIOD]=false","source_organisation_1":"Organisation for Economic Co-operation and Development (OECD)","source_periodicity_1":"Annual","source_geographical_coverage_1":"Canada","fr":{"SDG_GOAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments.</p>","SDG_INDICATOR":"<p>Indicateur 3.b.2 : Montant total net de l\u2019aide publique au d\u00e9veloppement consacr\u00e9 \u00e0 la recherche m\u00e9dicale et aux soins de sant\u00e9 de base.</p>","STAT_CONC_DEF":"<strong>D\u00e9finition :</strong>\n<br><br>\nD\u00e9caissements bruts du total de l\u2019Aide publique au d\u00e9veloppement (APD) re\u00e7ue de tous les donateurs pour les secteurs de la recherche m\u00e9dicale et de la sant\u00e9 de base.\n<br><br>\n<strong>Concepts :</strong>\n<br><br>\nAPD: Le Comit\u00e9 d\u2019aide au d\u00e9veloppement (CAD) d\u00e9finit l\u2019APD comme \u00ab les apports vers les pays et les territoires figurant sur la liste du CAD \u00e0 titre de b\u00e9n\u00e9ficiaires de l\u2019APD ou vers les institutions multilat\u00e9rales \u00bb, qui sont : \n<br><br>\ni) fournis par des organismes officiels, y compris les gouvernements des \u00c9tats et des collectivit\u00e9s locales, ou par leurs organismes de direction;\n<br><br>\nii) chaque op\u00e9ration est administr\u00e9e avec, pour principal objectif, la promotion du d\u00e9veloppement \u00e9conomique et de l\u2019am\u00e9lioration des conditions de vie dans les pays en d\u00e9veloppement; et est de nature pr\u00e9f\u00e9rentielle et comporte un \u00e9l\u00e9ment de subvention d\u2019au moins 25 % (calcul\u00e9 \u00e0 un taux d\u2019actualisation de 10 %). (Consulter le <a href=\"https://www.oecd.org/fr/topics/sub-issues/oda-eligibility-and-conditions/official-development-assistance--definition-and-coverage.html\">https://www.oecd.org/fr/topics/sub-issues/oda-eligibility-and-conditions/official-development-assistance--definition-and-coverage.html)</a>\n<br><br>\nLes secteurs de la recherche m\u00e9dicale et de la sant\u00e9 de base sont d\u00e9finis par le CAD. La recherche m\u00e9dicale fait r\u00e9f\u00e9rence au code de secteur du syst\u00e8me de notification des pays cr\u00e9anciers (SNPC) 12182 et la sant\u00e9 de base couvre tous les codes de la s\u00e9rie 122 (consulter le (en anglais seulement) : <a href=\"https://www.oecd.org/development/financing-sustainable-development/development-finance-standards/purposecodessectorclassification.htm\">https://www.oecd.org/development/financing-sustainable-development/development-finance-standards/purposecodessectorclassification.htm)</a>\n","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"   ","SDG_GOAL__GLOBAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET__GLOBAL":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments.</p>","SDG_INDICATOR__GLOBAL":"<p>Indicateur 3.b.2 : Montant total net de l\u2019aide publique au d\u00e9veloppement consacr\u00e9 \u00e0 la recherche m\u00e9dicale et aux soins de sant\u00e9 de base.</p>","source_active_1":true,"source_url_text_1":"SNPC: Syst\u00e8me de notification des pays cr\u00e9anciers (flux)","source_url_1":"https://data-explorer.oecd.org/vis?lc=fr&pg=0&snb=24&vw=tb&df[ds]=dsDisseminateFinalCloud&df[id]=DSD_CRS%40DF_CRS&df[ag]=OECD.DCD.FSD&df[vs]=1.3&dq=CAN.DPGC.122%2B12182.100._T._T.D.Q._T..&pd=2015%2C&to[TIME_PERIOD]=false","source_organisation_1":"Organisation de coop\u00e9ration et de d\u00e9veloppement \u00e9conomiques (OCDE)","source_geographical_coverage_1":"Canada","un_designated_tier":"Niveau I","un_custodian_agency":"Organisation de coop\u00e9ration et de d\u00e9veloppement \u00e9conomiques (OCDE)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0B-02.pdf","goal_meta_link_text":"M\u00e9tadonn\u00e9es des objectifs de d\u00e9veloppement durable des Nations Unies"},"national_metadata_updated_date":"2025-04-04","national_data_updated_date":"2025-04-03","target_number":"3.b","goal_number":"3","indicator_sort_order":"03-0b-02"}